prikaz prve stranice dokumenta Metformin
  Download
PDF 1.24 MB
master's thesis
Metformin
Zagreb: University of Zagreb, Faculty of Pharmacy and Biochemistry, 2019. urn:nbn:hr:163:985483
Tekić, Ina
University of Zagreb
Faculty of Pharmacy and Biochemistry
Department of medical biochemistry and haematology

Institutional repository: Repository of Faculty of Pharmacy and Biochemistry University of Zagreb

Cite this document

Tekić, I. (2019). Metformin (Master's thesis). Zagreb: University of Zagreb, Faculty of Pharmacy and Biochemistry. Retrieved from https://urn.nsk.hr/urn:nbn:hr:163:985483

Tekić, Ina. "Metformin." Master's thesis, University of Zagreb, Faculty of Pharmacy and Biochemistry, 2019. https://urn.nsk.hr/urn:nbn:hr:163:985483

Tekić, Ina. "Metformin." Master's thesis, University of Zagreb, Faculty of Pharmacy and Biochemistry, 2019. https://urn.nsk.hr/urn:nbn:hr:163:985483

Tekić, I. (2019). 'Metformin', Master's thesis, University of Zagreb, Faculty of Pharmacy and Biochemistry, accessed 28 November 2024, https://urn.nsk.hr/urn:nbn:hr:163:985483

Tekić I. Metformin [Master's thesis]. Zagreb: University of Zagreb, Faculty of Pharmacy and Biochemistry; 2019 [cited 2024 November 28] Available at: https://urn.nsk.hr/urn:nbn:hr:163:985483

I. Tekić, "Metformin", Master's thesis, University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, 2019. Available at: https://urn.nsk.hr/urn:nbn:hr:163:985483

Metadata
TitleMetformin
Title (english)Metformin
AuthorIna Tekić
MentorRoberta Petlevski (mentor)
Committee memberRoberta Petlevski (predsjednik povjerenstva)
Committee memberLidija Bach-Rojecky (član povjerenstva)
Committee memberŽeljka Vanić (član povjerenstva)
GranterUniversity of Zagreb
Faculty of Pharmacy and Biochemistry
(Department of medical biochemistry and haematology)
Zagreb
Defense date and country2019-09-30, Croatia
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Pharmacy
Medical Biochemistry
Abstract
Metformin, lijek sintetiziran još 20-ih godina prošlog stoljeća svoje odobrenje je dočekao tek 1994. godine. Sintetiziran je po uzoru na prirodni spoj galegin, izoliran iz Galege officinalis. Danas se koristi kao zlatni standard u terapiji šećerne bolesti tipa 2, a novija istraživanja pokazuju i njegovu širu primjenu. Metformin smanjuje glukozu u krvi i povećava inzulinsku osjetljivost. Glavna ciljna tkiva metformina su jetra i crijeva. U jetrima inhibira glukoneogenezu, a u crijevima smanjuje apsorpciju glukoze. Za liječenje šećerne bolesti tipa 2 koristi se kao monoterapija ili u kombiniranoj terapiji, a istraživanja upućuju i na ulogu metformina u prevenciji šećerne bolesti. Metformin također djeluje i na upalu i mikrobiotu crijeva. Kod šećerne bolesti tipa 1 može se primjenjivati kao dodatna terapija jer smanjuje potrebu za inzulinom. Nuspojave metformina su rijetke, a najčešće su gastro-intestinalne nuspojave. Uloga metformina u liječenju drugih bolesti još uvijek se istražuje.
Abstract (english)
Metformin, a drug synthesized in the 1920s, was not approved until 1994. It was modeled on the natural compound galegin, isolated from Galega officinalis. Today, it is used as the gold standard in type 2 diabetes, and more recent studies show its widespread use. Metformin lowers blood glucose and increases insulin sensitivity. The main target tissues of metformin are the liver and intestines. In the liver it inhibits gluconeogenesis, and in the intestine it decreases glucose absorption. For the treatment of Type 2 diabetes, it is used as monotherapy or in combination therapy, and research has suggested the role of metformin in the prevention of diabetes. Metformin also acts on inflammation and gut microbiota. Metformin can be used in Type 1 diabetes as an adjunctive therapy as it reduces the need for insulin. Metformin side effects are rare, most commonly gastro-intestinal side effects. The role of metformin in the treatment of other diseases is still under investigation.
Keywords
Keywords (english)
Languagecroatian
URN:NBNurn:nbn:hr:163:985483
Study programmeTitle: Medical biochemistry
Study programme type: university
Study level: integrated undergraduate and graduate
Academic / professional title: magistar/magistra medicinske biokemije i laboratorijske medicine (magistar/magistra medicinske biokemije i laboratorijske medicine)
Type of resourceText
File originBorn digital
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2021-04-27 13:59:51